STOCK TITAN

Concert Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Concert Pharmaceuticals (NASDAQ: CNCE) will present a corporate overview at two upcoming virtual investor conferences. The H.C. Wainwright Global Life Sciences Conference is scheduled for March 9, 2021, with on-demand access starting at 7:00 a.m. ET. The Oppenheimer Virtual 31st Annual Healthcare Conference will take place on March 17, 2021, at 9:20 a.m. ET. Interested parties can access the live webcasts on the company's website and will be available for replay for two weeks post-event.

Positive
  • None.
Negative
  • None.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming virtual investor conferences:

  • The H.C. Wainwright Global Life Sciences Conference on March 9, 2021, on-demand beginning at 7:00 a.m. ET; and
  • The Oppenheimer Virtual 31st Annual Healthcare Conference on March 17, 2021 at 9:20 a.m. ET.

A live webcast of the presentations may be accessed in the Investors section of the Company’s website at www.concertpharma.com. Please log on to the Concert website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Concert’s website for two weeks following the presentation.

About Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn.

FAQ

What is the schedule for Concert Pharmaceuticals' upcoming investor presentations?

Concert Pharmaceuticals will present at the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, and at the Oppenheimer Virtual 31st Annual Healthcare Conference on March 17, 2021.

How can I access the webcasts for Concert Pharmaceuticals' presentations?

The live webcasts for Concert Pharmaceuticals' presentations can be accessed through the Investors section of their website.

What is the ticker symbol for Concert Pharmaceuticals?

The ticker symbol for Concert Pharmaceuticals is CNCE.

When will the webcasts be available for replay?

The webcasts will be available for replay on the Concert Pharmaceuticals website for two weeks following the presentations.

What type of company is Concert Pharmaceuticals?

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing small molecule drugs.

Concert Pharmaceuticals Inc

NASDAQ:CNCE

CNCE Rankings

CNCE Latest News

CNCE Stock Data

46.03M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Lexington